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identification of putative natriuretic 
hormones isolated from human urine
Herbert J. Kramer*
Center of Internal Medicine, Rheinische-Friedrich-Wilhelms-University, Bonn, Germany, 
This brief review describes some representative methodological approaches to the isolation 
of putative endogenous inhibitors of epithelial sodium transport – i.e., as ouabain-like 
factors (OLF) that inhibit the sodium transport enzyme Na-K-ATPase or inhibit the epithelial 
sodium channel (ENaC). Gel chromatography and reverse-phase (RP)-high performance 
liquid chromatography (HPLC) of lyophilized and reconstituted 24 h-urine from salt-loaded 
healthy humans led to two active fractions, a hydrophilic OLF-1 and a lipophilic OLF-2, 
whose mass (Ms)-spectroscopic data indicate a Mr of 391 (1, 2). Further identification 
was attempted by Ms-, infrared (IR)-, ultraviolet (UV)-, and 1H-NMR-spectroscopy. 
OLF-1 and OLF-2 may be closely related if not identical to (di)ascorbic acid or its salts 
such as vanadium (V)-Vv-diascorbate with Mr 403 (3) and V
IV-diascorbate. OLF-1 and 
Vv-diascorbate are about 10-fold stronger inhibitors of Na-K-ATPase than OLF-2 and 
VIV-diascorbate, respectively. In conscious rats, i.v. infusion of OLF-1 and OLF-2 resulted 
in a strong natriuresis. In a similar study, Cain et al. (4) isolated a sodium transport inhibitor 
from the urine of uremic patients by gel chromatography and RP-HPLC. In uremic rats, 
a natriuretic response to the injection of the active material was found. Xanthurenic acid 
8-O-β-D-glucoside (Mr 368) and xanthurenic acid 8-O-sulfate (Mr 284) were identified as 
endogenous inhibitors of sodium transport acting, e.g., by ENaC blockade. No definite 
relation to blood pressure, body fluid volume, or sodium balance has been reported for any 
of these above factors, and further studies to identify the natriuretic and/or ouabain-like 
compound(s) or hormone(s) will be needed.
Keywords: sodium transport, natriuretic hormone, human urine, endogenous inhibitors, epithelial sodium 
transport
introduction – Background
With this brief review, some methological aspects of the isolation of putative endogenous membrane 
transport inhibitor(s) and natriuretic factor(s) will be described, and the results compared with those 
of similar attempts by other groups of investigators.
In 1969 (5), and in more detail in 1974 (6) and 1977 (7), we demonstrated for the first time that acute 
extracellular fluid volume (ECFV)-expansion in rats may release a natriuretic factor or “hormone,” 
which was postulated to act through inhibition of the sodium pump. Thus, ECFV-expansion was 
accompanied by a decrease in Na-K-ATPase in the renal cortex and the appearance of an inhibitor 
of Na-K-ATPase in the serum of these rats, respectively. Using gel chromatography, this inhibitory 
activity was also detected in the post-salt fraction of serum from ECFV-expanded dogs and in the 
serum and urine of salt-loaded humans. Besides the in vitro-assay of the inhibitory activity, we also 
demonstrated the inhibitory effect of this serum fraction on epithelial sodium transport, i.e., on 
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short-circuit current (SCC) and potential difference (PD) in the 
isolated frog skin (8). This fraction of serum or urine was also 
found to cause natriuresis in a rat bioassay. We concluded that a 
natriuretic factor emerges in the circulation with excessive salt load 
whose mechanism of action was to modulate the Na-K-ATPase 
enzyme in the vasculature as well as in the renal tubule.
Attempts to identify this humoral inhibitor(s), however, 
remained unsuccessful despite the use of extensive methodologic 
approaches. Besides an endogenous ouabain (9), several bufodi-
enolides (10) have been identified using the methods described in 
this paper of which two compounds with Mr of around 400 daltons 
will be considered in the present mini-review, namely vanadium 
(V)-diascorbate(s) and derivatives of xanthurenic acid (4). The 
compounds were assumed to be present in the circulation, and 
therefore may be excreted in the urine.
Ouabain-Like Factor(s) as endogenous 
Sodium Transport inhibitors
As source for isolation and identification of a putative natriuretic 
hormone and/or endogenous epithelial sodium transport enzyme 
inhibitor, we pooled large quantities (50–100  L) of urine from 
salt-loaded healthy humans, which was lyophilized to dryness and 
reconstituted with 0.01M acetic acid, and then subjected to gel chro-
matography using Sephadex G-25 and Sephadex G-10 columns.
Ouabain-Like Factors and vanadium-Diascorbic 
Acid: effects on na-K-ATPase
To detect the serum and urine fractions with the active 
compound(s), we employed an in  vitro-assay of Na-K-ATPase 
using a purified commercially available hog cerebral enzyme 
preparation. We also used this Na-K-ATPase membrane fraction 
as marker to follow-up activity with purification steps during 
the subsequent chromatographic steps. To detect the potential 
natriuretic activity, all fractions were screened for their natriuretic 
effect using a bioassay in conscious rats (11).
The transport enzyme Na-K-ATPase inhibitory and natriuretic 
activity(ies) eluted from the Sephadex G-25 column in a post-salt 
fraction. When this fraction was then subjected to gel chromatogra-
phy on Sephadex G-10, a strongly active enzyme inhibitory material 
eluted in a late fraction (1). This late fraction also showed a signifi-
cant natriuretic action (11). This enzyme inhibitory and natriuretic 
fraction was subjected to high performance liquid chromatography 
(HPLC), and subsequently to thin layer chromatography (TLC). 
Characterization of the active material was attempted by mass 
(Mr)-, nuclear magnetic resonance (1H-NMR)-, infrared (IR)-
spectroscopy (1), and ultraviolet (UV)-fluorescence/absorbance. 
The natriuretic activity was also studied by bioassay to identify the 
active compounds after gel filtration, reverse phase (RP)-HPLC, 
and amino acid analysis for its potential peptidic character (11).
Reverse-phase HPLC of this highly active late fraction from 
Sephadex G-10 resulted in two subfractions with significant Na-K-
ATPase enzyme inhibition. They were named ouabain-like factors 
(OLF); one eluted in the water phase as the more polar hydrophilic 
OLF-1; the second eluted in a later phase at 20% acetonitrile as 
the more apolar lipophilic OLF-2. These fractions also produced 
a significant natriuresis (see below).
Analysis of Chemical Structure
Both compounds showed signals for hydroxyl and carboxyl groups 
as well as criteria for esters or lactones (a precursor of ascorbic acid 
in plants and animals is L-gulono-y-lactone, and 2,3-diketogulo-
nic acid is an oxidation product of ascorbic acid). No signals for 
aromatic, aliphatic, heterocyclic, or steroid structures were found. 
Whereas the IR-spectrum of OLF-1 is different from that of OLF-2 
(1), UV-, Mr-, and 1H-NMR-criteria were similar and fluorescence 
of both compounds when separated by TLC required the presence 
of a dicarboxylic acid-like conformation; dicarboxylic acid [see also 
Ref. (11): Asp, Glu as carboxylic acids] is an organic compound 
containing two carboxyl functional groups (–COOH). IR- and 1H-
NMR spectra of OLF-1 and OLF-2 suggest a chemical structure 
resembling a sugar or sugar derivative. However, sugars are not 
fluorescent as are the OLF recovered from TLC. Therefore, these 
data suggest the unknown compounds to be identical with ascorbic 
acid or its salts such as Vv-diascorbate and VlV-diascorbate, respec-
tively, with Mr 403 (3). The superscript roman numbers indicate the 
oxidative state of vanadium (V): VlV oxide (V2O5), the most stable 
oxygen combination, and VlV oxide (VO2) represent two of the four 
oxygen states of vanadium. V-diascorbates elute from the RP-HPLC 
column at similar elution times and acetonitrile gradients as the 
hydrophilic and lipophilic OLF-1 and OLF-2, respectively. VIV-
diascorbate also showed the same UV-maximum as we found for 
OLF. Thus, ascorbic acid seems to be an important cornerstone 
of the structure of the yet unknown humoral ATPase inhibitor.
It is noteworthy that the water solubility of the individual 
ascorbic acid salts of metals varies remarkably, and it may be 
assumed that Vv- and VlV diascorbates with their different water 
solubility elute from the RP-HPLC column at similar elution 
times as the OLF-1 and OLF-2, respectively. V-diascorbates 
also show the same UV-maximum as the OLF and are strong 
candidates for the urinary hydrophilic OLF-1 and lipophilic 
OLF-2, respectively.
Effects on Enzyme Kinetics
These active subfractions, containing OLF-1 and OLF-2, were 
further purified by two-dimensional preparative TLC to single 
compounds, whose mass spectroscopic (MS) data suggested a Mr 
of around 400. Actually, OLF-2, which dose-dependently inhibited 
Na-K-ATPase, was found to have a Mr of 391 (1). With respect to 
the effects of OLF-1 and OLF-2 and of Vv- and VlV-diascorbates on 
Na-K-ATPase enzyme activity and kinetics, in vitro studies showed 
that OLF-1 and OLF-2 inhibited the enzyme in its E2 configuration. 
In analogy to the polar OLF-1, which revealed an approximately 
10-fold stronger enzyme inhibition (IC50 1.5 × 10−5 M) than the 
apolar OLF-2 (IC50 1.5 × 10−4 M), we found that Vv-diascorbate 
(IC50 2 ×  10−6 M) is a significantly stronger inhibitor of Na-K-
ATPase than VIV-diascorbate (IC50 of 9 × 10−5 M) (3, 5, 12). In this 
context, I should mention that we found previously that certain 
trace metals are strong inhibitors of this enzyme (13).
Renal and Vascular Mechanisms of Action of OLF
Regarding the potential mechanism of the physiological and patho-
logical effects of OLF-1 and OLF-2 on vascular smooth muscle cells 
(VSMCs) and inner medullary collecting duct cells (IMCD cells), 
we found in an in vitro-assay that OLF-1 and OLF-2 enhanced 
May 2015 | Volume 6 | Article 663
Kramer Identification of putative natriuretic hormones isolated from human urine
Frontiers in Endocrinology | www.frontiersin.org
VSMC contractility by increasing intracellular Ca2+ similar to 
the effect of ouabain (14, 15). Similar effects were found with 
OLF-1 and OLF-2 on intracellular Ca2+ in IMCD cells, suggesting 
inhibition of tubular Na-reabsorption and thus regulating renal 
excretion, i.e., to enhance Na-excretion (16).
Ouabain-Like Factors and v-Diascorbates: 
natriuretic effects
For demonstration of the natriuretic activity, we used a bioassay 
in conscious rats (12). As mentioned above, in our assay system, 
the post-salt fraction IV from Sephadex G-25 was applied to 
Sephadex-G-10 and resulted in a late fraction, which was applied 
to RP-HPLC. When administered i.v., OLF-1 resulted in an 
immediate, eightfold rise in natriuresis from approximately 1 to 
8 μEq/min/mg, whereas the apolar OLF-2 caused a natriuresis of 
slower onset reaching its maximum after 60 min and lasting for 
more than 180 min. This was confirmed also by injection of the 
active fractions obtained by quantitative TLC.
natriuretic Factor Unrelated to OLF
Finally, I should mention that we described previously a natriuretic 
compound, which we suggested to be a peptide. Thus, when the 
pooled post-salt natriuretic urine fraction obtained by gel chroma-
tography (see above) was subjected to repetitive RP-HPLC, a late 
eluting fraction showed strong natriuretic activity in the bioassay 
and was associated with a fluorescence peak when treated with 
o-phthaldialdehyde as a marker for primary amines (11). Amino 
acid analysis before and after total acid hydrolysis suggested a 
peptide tentatively containing the amino acids (AA) Asp, Glu, Gly, 
Phe, and Ser (1, 11). The natriuretic activity was lost after incuba-
tion with chymotrypsin, which splits bonds with aromatic AA (2). 
We found, in addition, that several synthetic (mono-) peptides 
of di- and tri-AA are significantly natriuretic when injected i.v. 
(unpublished data).
Xanthurenic Acid 8-O-β-D-Glucoside and 
Xanthurenic Acid 8-O-Sulfate as 
endogenous Sodium Transport inhibitors
Cain et al. (4) followed a protocol very similar to that of Kramer 
et al. for isolation of the natriuretic activity except that they used 
the urine of uremic patients as source of the inhibitor and a bioas-
say in (conscious?) uremic rats. As marker for the active material, 
Cain et al. used changes of the SCC of the isolated frog skin – as 
we described in 1977 (8) – for monitoring transepithelial sodium 
transport inhibitory activity. For monitoring its natriuretic effect, 
the above mentioned bioassay in uremic rats was used. A direct 
in vitro-assay for inhibition of the Na-K-ATPase enzyme by the 
natriuretic factor or “hormone” was not employed. The authors 
rather speculate that the natriuretic hormone may act via other 
sodium pumps in the kidney, e.g., the epithelial sodium channel 
(ENaC) in the distal tubule.
Xanthurenic Acid Derivatives: effects on 
epithelial Sodium Transport
Epithelial sodium transport was measured as changes of SCC 
and PD in the isolated frog skin. For isolation and identification 
of the transport inhibitor, one gel chromatographic step and 
three consecutive HPLC steps were applied. Final identification 
was achieved by mass (Ms)-, IR-, UV-, and NMR-spectroscopy. 
Purification of the activity was estimated from UV peak with a 
characteristic spectrum at 338 nm. Xanthurenic acid 8-O-β-D-
glucoside (Mr 368) and xanthurenic acid 8-O-sulfate (Mr 284) 
were identified as the endogenous sodium transport (ENaC, 
Na-K-ATPase) inhibitors.
Xanthurenic Acid Derivatives: natriuretic effects
The material (Mr 368) obtained from two HPLC runs was tested 
for natriuretic effect in their uremic rat bioassay. Urinary sodium 
excretion rose immediately and reached its maximum approxi-
mately 40 min after intra-arterial infusion (5). Urinary volume 
increased slightly and then decreased to below baseline, i.e., a 
decrease in urine volume with a rise in urinary osmolality.
A pathophysiological role of xanthurenic acid, a tryptophane 
derivative, is difficult to envisage as this uremic toxin may inhibit 
transmembranous sodium transport independent of a potential 
role as specific circulating natriuretic or sodium transport inhib-
iting “hormone.” Thus, although Bricker et  al. showed that the 
natriuretic action of the isolated inhibitor paralleled the changes in 
renal function, as an alternative explanation, it may be reasonable 
to assume that with the progressive decrease in renal function 
and the accumulation of toxic metabolites, the rise in fractional 
sodium excretion may parallel the urinary concentration of the 
xanthurenic derivatives.
Summary
Although there is no doubt that an as yet unidentified natriuretic 
compound can be isolated from human urine by gel filtration and 
RP-HPLC, whose activity changes in parallel with salt (sodium 
chloride) intake, i.e., it correlates with salt-balance (low or high 
salt intake). Therefore, the activity may be related to an as yet 
unidentified “natriuretic hormone” that is assumed to play a crucial 
role in the fine-tuning of renal tubular sodium handling and may 
thus be involved in the long-term body fluid and blood pressure 
regulation.
We found two Na-K-ATPase inhibitors, the hydrophilic 
OLF-1 and the lipophilic OLF-2 (1). The hydrophilic form was 
more potent than the lipophilic one. The lipophilic compound 
was moderately natriuretic but strong ATPase inhibitor. Both 
compounds showed UV fluorescence/absorbance of lower 
intensity in the hydrophilic (hydrated) form. Both enzyme 
inhibitors showed UV-absorbance, which requires the presence 
of a dicarboxylic acid-like arrangement (1). In addition, from our 
data the unknown compound(s) most likely fulfill(s) the criteria 
for lactones.
Unfortunately, for none of the three classes of endogenous 
sodium transport inhibitors, a physiologic or pathophysiologic role 
was demonstrated, i.e., no correlation to body fluid and sodium 
balance or blood pressure was documented. Thus, further studies 
are required to confirm the structures of the various endogenous 
factors; final identification of their physiological and pathophysi-
ological significance must await urgent results of additional well-
designed studies.
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